Online citations, reference lists, and bibliographies.
← Back to Search

Mesothelioma With Rhabdoid Features: An Ultrastructural And Immunohistochemical Study Of 10 Cases

N. Ordóñez
Published 2006 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
Mesotheliomas with rhabdoid morphology are rare and only two individual case reports have been documented in the literature. This author reports a series of 10 cases of mesotheliomas with rhabdoid features, nine of which originated in the pleura and one in the peritoneum. Eight of the patients were men and two were women. Six patients had a history of asbestos exposure. Histologically, seven of the mesotheliomas were epithelioid, two sarcomatoid, and one biphasic. The proportion of the rhabdoid cells seen in these cases constituted 15–75% of the individual tumors. Cytoplasmic staining in the rhabdoid cells was seen for pan-keratin and vimentin in all 10 cases, for keratin 7 in eight of eight, for calretinin in nine of 10, and for keratin 5/6 in seven of nine. Nuclear positivity for WT1 was observed in the rhabdoid cells of four of seven cases and membranous reactivity for mesothelin in four of six, and for podoplanin in two of six. Only one case showed desmin positivity in sparse cells in the nonrhabdoid component of the tumor. All of the cases were negative for CEA, MOC-31, TAG-72, CD15, CD34, bcl2, muscle-specific actin, and TTF-1. Ultrastructural studies revealed paranuclear collections of intermediate filaments, but no evidence of rhabdomyoblastic differentiation was seen. The mean survival of five of the six patients for whom this information was available was 3.8 months. The remaining patient had a survival time of 1 year. It is important for pathologists to be aware that mesotheliomas can present rhabdoid features, not only because they can be confused with other malignancies that can exhibit a similar morphology, but also because of their apparently unusually aggressive behavior. The value of immunohistochemistry and electron microscopy in the differential diagnosis of these tumors is discussed.
This paper references
10.1097/00000478-199903000-00001
Congenital disseminated malignant rhabdoid tumor: a distinct clinicopathologic entity demonstrating abnormalities of chromosome 22q11.
F. White (1999)
10.1097/00000478-199612000-00001
Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases.
B. T. Lin (1996)
10.1002/(SICI)1096-9896(199704)181:4<362::AID-PATH764>3.0.CO;2-Y
bcl‐2 EXPRESSION IN PLEURAL AND EXTRAPLEURAL SOLITARY FIBROUS TUMOURS
M. Chilosi (1997)
10.1097/00000478-200010000-00021
Deciduoid epithelial mesothelioma of the pleura with focal rhabdoid change.
L. Puttagunta (2000)
10.1111/j.1365-2559.1987.tb01847.x
Rhabdoid tumour of the bladder: a histological, ultrastructural and immunohistochemical study
M. Harris (1987)
10.1043/1543-2165(2004)128<686:MMWARP>2.0.CO;2
Malignant melanoma with a rhabdoid phenotype: histologic, immunohistochemical, and ultrastructural study of a case and review of the literature.
J. J. Abbott (2004)
Malignant rhabdoid tumor of the kidney and soft tissues. Evidence for a diverse morphological and immunocytochemical phenotype.
M. Tsokos (1989)
10.1016/S0002-9440(10)65285-6
Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
S. Breiteneder-Geleff (1999)
10.1097/00000478-199903000-00004
Synovial sarcoma of the extremities: a clinicopathologic study of 34 cases, including semi-quantitative analysis of spindled, epithelial, and poorly differentiated areas.
S. K. Machen (1999)
10.1002/1097-0142(197805)41:5<1937::AID-CNCR2820410538>3.0.CO;2-U
Histopathology and prognosis of Wilms tumor Results from the first national wilms' tumor study
J. Beckwith (1978)
10.1038/modpathol.3880368
Proximal-Type Epithelioid Sarcoma: A Clinicopathologic Study of 20 Cases
T. Hasegawa (2001)
10.1097/00000478-200105000-00007
Calretinin and Other Mesothelioma Markers in Synovial Sarcoma: Analysis of Antigenic Similarities and Differences With Malignant Mesothelioma
M. Miettinen (2001)
10.1053/HUPA.2001.28252
Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic?
C. Fuller (2001)
Cytogenetics of synovial sarcoma. Presentation of 10 new cases and review of the literature. Genes Chromosomes Cancer 1991;3:338–345
J Limon (1991)
Molecular analysis of a partial deletion in a central nervous system rhabdoid tumor. Genes Chromosomes Cancer 1992;5:104–108
JA Biegel (1992)
10.1038/28212
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
I. Versteege (1998)
Malignant rhabdoid tumor of the liver. A case report
MP Foschini (1992)
10.1007/BF00713281
The existence of rhabdoid cells in specified soft tissue sarcomas. Histopathological, ultrastructural and immunohistochemical evidence.
M. Tsuneyoshi (1987)
10.1016/0090-3019(92)90014-E
Malignant rhabdoid tumor of the central nervous system with subarachnoid dissemination.
A. Agranovich (1992)
10.1043/1543-2165(2003)127<1161:ESNIBO>2.0.CO;2
Epithelioid sarcoma: new insights based on an extended immunohistochemical analysis.
W. Laskin (2003)
10.1016/0046-8177(95)90254-6
Expression of muscle actins in diffuse mesotheliomas.
I. T. Kung (1995)
10.1016/0046-8177(94)90243-7
Desmin and neural marker expression in mesothelial cells and mesotheliomas.
J. Hurlimann (1994)
10.1080/00313020120038728
SYNOVIAL SARCOMA AND MALIGNANT MESOTHELIOMA OF THE PLEURA: REVIEW, DIFFERENTIAL DIAGNOSIS AND POSSIBLE ROLE OF APOPTOSIS
F. Cappello (2001)
10.1016/S0046-8177(81)80050-0
Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children.
J. Haas (1981)
10.1016/0046-8177(90)90034-3
Synovial sarcoma: an immunohistochemical and ultrastructural study.
N. Ordóñez (1990)
10.1002/gcc.10052
Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors
K. Uno (2002)
10.1093/AJCP/105.2.182
Lung tumors with a rhabdoid phenotype.
A. Cavazza (1996)
10.1053/ADPA.2002.36657
Adenocarcinomas of the gastrointestinal tract with prominent rhabdoid features.
M. Amrikachi (2002)
10.1097/00000478-199110000-00010
Undifferentiated carcinoma of the vulva mimicking epithelioid sarcoma.
E. Kudo (1991)
10.1097/00000478-199410000-00006
Congenital "neurovascular hamartoma" of the skin. A possible marker of malignant rhabdoid tumor.
A. Perez-Atayde (1994)
10.1097/00000478-199702000-00002
"Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series.
L. Guillou (1997)
10.1038/modpathol.3880543
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas
H. Kahn (2002)
10.1038/modpathol.3800544
The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study
N. Ordóñez (2006)
10.1111/j.1365-4362.1992.tb02695.x
RHABDOID TUMOR OF THE SKIN
O. Sangueza (1992)
10.1046/j.1365-2559.2000.00906.x
Rhabdoid tumour of the lung is a dedifferentiated phenotype of pulmonary adenocarcinoma
J. Miyagi (2000)
10.1097/00022744-200206000-00014
Diagnostic Use of Muscle Markers in the Cytologic Evaluation of Serous Fluids
A. Afify (2002)
10.1080/01913120309949
Pulmonary Large Cell Carcinoma with Rhabdoid Phenotype
K. Hiroshima (2003)
10.1078/0344-0338-00170
Pseudomesotheliomatous adenocarcinoma of the lung with rhabdoid features.
J. Attems (2001)
10.1097/00125480-200007020-00007
Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas.
N. Ordóñez (2000)
Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion.
M. Wick (1995)
10.1093/AJCP/94.5.645
Malignant rhabdoid tumor of the liver. A distinct clinicopathologic entity.
S. Hunt (1990)
10.1046/j.1365-2559.2001.01157.x
Combined use of novel epithelial (MOC‐31) and mesothelial (HBME‐1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura
C. González-Lois (2001)
10.1016/S0022-5347(17)54067-7
'Rhabdoid' Wilms' tumor: an ultrastructural study.
C. H. Fung (1981)
10.1097/00000478-200109000-00005
Are Myogenin and MyoD1 Expression Specific for Rhabdomyosarcoma?: A Study of 150 Cases, With Emphasis on Spindle Cell Mimics
M. Cessna (2001)
10.1111/j.1365-2559.1992.tb00947.x
Metastatic malignant melanoma showing a rhabdoid phenotype: further evidence of a non‐specific histological pattern
L. Bittesini (1992)
10.1046/j.1365-2559.1998.00405.x
A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours
Garcia‐Prats (1998)
10.1046/j.1365-2559.2003.01686.x
The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet‐derived growth factor‐receptor, P‐glycoprotein and Bcl‐2
R. Attanoos (2003)
10.1053/ADPA.2003.50007
Thymic carcinoma with rhabdoid features.
T. H. Toprani (2003)
10.3109/15513818309048287
Absence of immunoperoxidase staining for myoglobin in the malignant rhabdoid tumor of the kidney.
J. Rutledge (1983)
10.1097/00000478-200111000-00008
The Role of Desmin and N-Cadherin in Effusion Cytology: A Comparative Study Using Established Markers of Mesothelial and Epithelial Cells
B. Davidson (2001)
10.3171/JNS.1990.73.5.0710
Monosomy 22 in rhabdoid or atypical tumors of the brain.
J. Biegel (1990)
10.1002/GCC.2870030504
Cytogenetics of Synovial Sarcoma: Presentation of Ten New Cases and Review of the Literature
J. Limon (1991)
10.1016/S0002-9440(10)62311-5
Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.
V. Schacht (2005)
Metastatic malignant melanoma with ‘rhabdoid
ES Chang (1994)
D2-40 is a novel new marker of malignant mesothelioma (MM): tissue microarray study of 45 MM vs 409 lung carcinomas and primary non-mesothelial neoplasms of the pleura and chest wall
A Sienko (2005)
10.1002/GCC.2870020308
Malignant rhabdoid tumor: A highly malignant childhood tumor with minimal karyotypic changes
E. Douglass (1990)
10.1093/AJCP/93.3.305
The diagnostic utility of desmin. A study of 584 cases and review of the literature.
L. Truong (1990)
10.1111/j.1440-1827.1996.tb03627.x
Localized malignant peritoneal mesothelioma containing rhabdoid cells
S. Matsukuma (1996)
10.1016/0165-4608(87)90147-6
A consistent chromosome translocation in synovial sarcoma.
Sandra Smith (1987)
10.1016/J.HUMPATH.2005.01.019
D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
N. Ordóñez (2005)
10.1111/j.1365-2559.1992.tb00946.x
Malignant rhabdoid tumour of the liver. A case report
M. Foschini (1992)
10.1111/j.1365-2559.1992.tb00430.x
Intermediate filament expression in mesotheliomas: leiomyoid mesotheliomas are not uncommon
F. Mayall (1992)
10.1016/S0046-8177(87)80161-2
Malignant rhabdoid tumor of the central nervous system.
P. J. Biggs (1987)
10.1002/GCC.2870050203
Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor
J. Biegel (1992)
10.1136/THORAX.55.10.860
Malignant vascular tumours of the pleura in "asbestos" workers and endothelial differentiation in malignant mesothelioma.
R. Attanoos (2000)
10.1016/S0022-5347(17)34900-5
Malignant fibrous histiocytoma of the bladder with focal rhabdoid tumor differentiation.
S. Egawa (1994)
10.1038/modpathol.3800259
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma
Albert Y Chu (2005)
10.1038/modpathol.3800471
The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study
N. Ordóñez (2006)
10.1097/00000478-200308000-00001
The Immunohistochemical Diagnosis of Mesothelioma: A Comparative Study of Epithelioid Mesothelioma and Lung Adenocarcinoma
N. Ordóñez (2003)
10.1016/S0046-8177(85)80036-8
Malignant soft tissue neoplasms with the histologic features of renal rhabdoid tumors: an ultrastructural and immunohistochemical study.
M. Tsuneyoshi (1985)
Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis.
S. Breiteneder-Geleff (1997)
10.1097/00000478-199807000-00008
Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract.
S. Suster (1998)
10.1111/j.1440-1827.2005.01791.x
Podoplanin as a marker for mesothelioma
Noriko Kimura (2005)
10.1016/J.HUMPATH.2003.07.019
Carcinoma of lung with rhabdoid features.
P. Tamboli (2004)
10.1038/modpathol.3880179
Myogenin is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues
S. Kumar (2000)
10.1097/00000478-199303000-00011
Vimentin-Negative Epithelioid Sarcoma: The Value of an Immunohistochemical Panel That Includes CD34
D. Arber (1993)
10.1016/S0046-8177(99)90247-2
Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis.
M. Miettinen (1999)
10.1016/0030-4220(88)90194-6
Malignant rhabdoid tumor of the tongue. A case report with immunohistochemical and ultrastructural findings.
M. Patrón (1988)
Malignant rhabdoid tumor: a highly malignant childhood tumor with minimal karyotypic changes. Genes Chromosomes Cancer 1990;2:210–216
EC Douglass (1990)
10.1038/modpathol.3800067
Diffuse malignant mesothelioma of the peritoneum and pleura, analysis of markers
J. Trupiano (2004)
10.1093/AJCP/102.4.426
Metastatic malignant melanoma with "rhabdoid" features.
E. S. Chang (1994)



This paper is referenced by
10.1016/J.ANNDIAGPATH.2006.10.001
The Toker tumor: spectrum of morphologic features in primary neuroendocrine carcinomas of the skin (Merkel cell carcinoma).
J. Plaza (2006)
10.1016/j.jtho.2019.08.2506
EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach.
A. Nicholson (2019)
10.1016/j.anndiagpath.2010.05.008
Podoplanin, a novel marker for seminoma: A comparison study evaluating immunohistochemical expression of podoplanin and OCT3/4.
M. Idrees (2010)
10.1002/DC.20620
Primary pleural epithelioid hemangioendothelioma with rhabdoid phenotype: Report and review of the literature
A. Saqi (2007)
10.1080/00313020802579250
Diagnosis of epithelial mesothelioma using tree‐based regression analysis and a minimal panel of antibodies
S. Klebe (2009)
10.1038/modpathol.2008.125
Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review
S. Klebe (2008)
10.1016/j.prp.2009.01.003
Pediatric extra-renal rhabdoid tumors with unusual morphology: a diagnostic pitfall for small biopsies.
R. Alaggio (2009)
10.1007/978-0-387-72114-9_12
Neoplasms of the Pleura
S. Hammar (2008)
10.1038/modpathol.2012.105
Deciduoid mesothelioma: report of 21 cases with review of the literature
N. Ordóñez (2012)
10.1016/B978-0-7020-3369-8.00013-6
Chapter 13 – Pleura and chest wall
B. Corrin (2011)
10.1007/978-0-387-72114-9_4
Common Non-Small-Cell Carcinomas and Their Variants
D. Flieder (2008)
10.1007/978-3-030-36438-0_22
Mesothelial Tumors of the Pleura
A. Weissferdt (2020)
Aggressive Malignant Mesothelioma In A Patient Without Previous Asbestos Exposure
Atharina Julai (2017)
10.1007/978-3-662-50491-8_21
Diseases of the Pleura
H. Popper (2017)
10.1038/modpathol.2011.202
Mesotheliomas with small cell features: report of eight cases
N. Ordóñez (2012)
10.4081/RT.2010.E46
Sarcomatous malignant peritoneal mesothelioma with large bowel involvement
Tomoaki Kaneko (2010)
10.1007/978-3-540-30760-0_12
Pathologic characterization and differential diagnosis of malignant peritoneal mesothelioma.
N. Ordóñez (2007)
10.14670/HH-25.1287
Lung carcinoma with rhabdoid component. A series of seven cases associated with uncommon types of non-small cell lung carcinomas and alveolar entrapment.
F. Izquierdo-García (2010)
10.1016/j.humpath.2017.07.015
The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
A. Marchevsky (2017)
10.1111/j.1365-2559.2012.04220.x
Diffuse pleural mesothelioma with epithelioid and angiosarcomatous components – a hitherto undescribed pattern of differentiation
A. Klabatsa (2012)
10.1097/01.pas.0000213417.00386.74
Histologic Variants of Papillary and Follicular Carcinomas Associated With Anaplastic Spindle and Giant Cell Carcinomas of the Thyroid: An Analysis of Rhabdoid and Thyroglobulin Inclusions
J. Albores-Saavedra (2007)
10.1043/2010-0086-RAR.1
Sarcomatoid neoplasms of the lung and pleura.
W. Travis (2010)
10.1111/j.1365-2559.2008.03181.x
The challenge of classifying poorly differentiated tumours in the lung
W. Wallace (2009)
10.1016/B978-0-323-44732-4.00023-6
Disorders of the Peritoneum
J. Watkins (2018)
10.1038/modpathol.2012.172
Mesothelioma with signet-ring cell features: report of 23 cases
N. Ordóñez (2013)
10.1111/his.12083
Primary rhabdoid adrenocortical carcinoma: a clinicopathological and immunohistochemical study of three cases
A. Weissferdt (2013)
10.5858/arpa.2012-0214-OA
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
A. Husain (2013)
10.1111/j.1365-2559.2012.04216.x
Re‐audit of revised method for assessing the mitotic component of histological grade in needle core biopsies of invasive carcinoma of the breast
A. Lee (2012)
10.5858/arpa.2012-0142-CR
Diffuse malignant mesothelioma.
S. Oviedo (2012)
Aspects cliniques et histopathologiques du mésothéliome pleural malin chez l’enfant et l’adulte jeune : à propos d’une série de 47 cas
Christelle Combaz-Lair (2015)
10.1111/pin.12623
SMARCB1/INI1/BAF47‐ deficient pleural malignant mesothelioma with rhabdoid features
Noriko Kimura (2018)
10.1007/978-1-4471-2825-0_16
Malignant Mesothelioma: Pathology
S. Anttila (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar